There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report), Envista Holdings (NVST – Research Report) and TELA Bio (TELA – Research Report) with bullish sentiments. DENTSPLY SIRONA (XRAY) In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on DENTSPLY SIRONA, with a price target of $44.00. The company's shares closed last Wednesday at $36.27, close to its 52-week low of $33.78. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-envista-holdings-nvst-and-tela-bio-tela?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more DENTSPLY SIRONA Charts.